Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Business

Oxygen Biotherapeutics, Inc. Nixes Deal With Swiss Firm

March 2, 2012

4 min read

Business

Oxygen Biotherapeutics, Inc. Announces Third Quarter FY2012 Financial Results Conference Call and Webcast

February 23, 2012

1 min read

Business

Oxygen Biotherapeutics, Inc. and Aurum Biosciences Enter Joint Research Agreement to Develop an Oxycyte(R)-Based Diagnostic Tool and Therapeutic for Acute Ischemic Stroke

February 1, 2012

1 min read

Drug Development

Oxygen Biotherapeutics, Inc. to Begin Clinical Study to Determine Efficacy of Dermacyte(R) in Relieving Histamine Induced Pruritus

January 9, 2012

1 min read

Business

Oxygen Biotherapeutics, Inc. Names Two New Board Members With Pharmaceutical Industry, Product and Business Development Emphasis

December 19, 2011

1 min read

Bio NC

Oxygen Biotherapeutics, Inc. Announces Registered Financing for up to $7.5 Million in Gross Proceeds

December 9, 2011

5 min read

Bio NC

Oxygen Biotherapeutics, Inc. to Present at 23rd Annual Piper Jaffray Healthcare Conference

November 22, 2011

1 min read

Bio NC

Oxygen Biotherapeutics, Inc. to Voluntarily Withdraw Secondary Listing From SIX Swiss Stock Exchange

October 28, 2011

1 min read

Bio NC

Why Oxygen Biotherapeutics, Inc. Ousted Its CEO; Audit Report Exposes All

September 27, 2011

1 min read

Business

Oxygen Biotherapeutics, Inc. Reports First Quarter FY2012 Financial Results and Announces Conference Call and Webcast for Shareholders

September 20, 2011

1 min read

JOBS